- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06812533
- Original Trial
Alleviant ALLAY-HFrEF Study
August 12, 2026 updated by: Alleviant Medical, Inc.
Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
350
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stacia Kraus
- Phone Number: 612-387-4552
- Email: stacia.kraus@alleviantmedical.com
Study Locations
-
-
Victoria
-
Clayton, Victoria, Australia, 3068
- Recruiting
- Monash Health Victorian Heart Hospital
-
Principal Investigator:
- Robert Gooley
-
Melbourne, Victoria, Australia, 3004
- Recruiting
- Alfred Hospital
-
Principal Investigator:
- David Kaye
-
-
-
-
-
Aalst, Belgium
- Recruiting
- OLV Hospital
-
Principal Investigator:
- Jozef Bartunek, Prof.
-
Antwerp, Belgium
- Recruiting
- ZAS Middelheim
-
Principal Investigator:
- Stefan Verheye
-
Bruges, Belgium
- Recruiting
- Az Sint Jan Brugge
-
Principal Investigator:
- Jan Van der Heyden, Prof.
-
-
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 2P6
- Recruiting
- Southlake Regional Hospital Centre
-
Principal Investigator:
- Liane Porepa, MD
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 0C1
- Recruiting
- Centre Hospitalier de l'Universite de Montreal (CHUM)
-
Principal Investigator:
- Brian Potter, MD
-
Montreal, Quebec, Canada, H2X 0C1
- Recruiting
- Centre Integre Universitaire de Sainte et de Services Scoiiaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS)
-
Principal Investigator:
- Benoit Daneault, MD
-
Québec, Quebec, Canada, G1V 4G5
- Recruiting
- IUCPQ - Université Laval (Quebec)
-
Principal Investigator:
- Josep Rodés-Cabau, MD, PhD
-
-
-
-
-
Tbilisi, Georgia
- Recruiting
- Tbilisi Heart and Vascular
-
Principal Investigator:
- Tamaz Shaburishvili
-
-
-
-
-
Athens, Greece, 15123
- Recruiting
- Hygeia Hospital
-
Principal Investigator:
- Elias Tsougos
-
Athens, Greece, 11527
- Recruiting
- Hippocration General Hospital Athens
-
Principal Investigator:
- Konstantinos Toutouzas
-
Thessaloniki, Greece
- Recruiting
- European Interbalken Medical Center
-
Principal Investigator:
- Vlasis Ninios
-
-
-
-
-
Tel Aviv, Israel
- Recruiting
- Tel Aviv Sourasky Medical Center
-
Principal Investigator:
- Michael Laufer-Perl
-
Zrifin, Israel
- Recruiting
- Shamir Medical Center
-
Principal Investigator:
- Gil Moravsky
-
-
-
-
-
Christchurch, New Zealand, 8011
- Recruiting
- Christchurch Hospital
-
Principal Investigator:
- Richard Troughton
-
Dunedin, New Zealand, 9016
- Recruiting
- Dunedin Hospital
-
Principal Investigator:
- Gerard Wilkins
-
-
-
-
-
Opole, Poland
- Recruiting
- University Clinical Hospital in Opole
-
Principal Investigator:
- Jerzy Sacha
-
Warsaw, Poland
- Recruiting
- Narodowy Instytut Kardiologii im. Stefana kardynała Wyszyńsk
-
Principal Investigator:
- Przemysław Leszek
-
Wroclaw, Poland
- Recruiting
- Uniwesytecki Szpital Kliniczny
-
Principal Investigator:
- Jan Biegus, Prof.
-
-
-
-
-
A Coruña, Spain
- Recruiting
- Hospital Universitario A Coruña
-
Principal Investigator:
- Maria Generosa Crespo Leiro, Prof.
-
Barcelona, Spain, 08036
- Recruiting
- Hospital Clinic de Barcelona
-
Principal Investigator:
- Omar Abdul-Jawad Altisent
-
Barcelona, Spain, 08025
- Recruiting
- Hospital de la Santa Creu i Sant Pau
-
Principal Investigator:
- Sonia Mirabet, MD, PhD
-
Barcelona, Spain
- Recruiting
- Vall d'Hebron University Hospital Barcelona
-
Principal Investigator:
- Eduardo Rodenas-Alesina
-
Madrid, Spain, 28041
- Recruiting
- Hospital Universitario 12 de Octubre
-
Principal Investigator:
- Javier de Juan Bagudá
-
Madrid, Spain, 28222
- Recruiting
- Hospital Universitario Puerta de Hierro
-
Principal Investigator:
- Marta Cobo Marcos, Prof.
-
Salamanca, Spain
- Recruiting
- Hospital Clínico Universitario de Salamanca
-
Principal Investigator:
- David González Calle, MD
-
Valencia, Spain, 46010
- Recruiting
- Valencia Hospital Clinico
-
Principal Investigator:
- Julio Nunez
-
-
-
-
California
-
Los Angeles, California, United States, 90033
- Recruiting
- Keck Medical Center of USC
-
Principal Investigator:
- Michael Fong, MD
-
Los Angeles, California, United States, 90095
- Recruiting
- University California Los Angeles Medical Center
-
Principal Investigator:
- Richard Cheng, MD
-
Sacramento, California, United States, 95817
- Recruiting
- UC Davis Medical Center
-
Principal Investigator:
- Tai Pham, MD
-
San Diego, California, United States, 92121
- Recruiting
- Scripps Clinical Research Services
-
Principal Investigator:
- Rajeev Mohan, MD
-
San Francisco, California, United States, 94143
- Recruiting
- University of California San Francisco
-
Principal Investigator:
- Liviu Klein, MD
-
-
Florida
-
Delray Beach, Florida, United States, 33484
- Recruiting
- Delray Medical Center
-
Principal Investigator:
- Philip Habib, MD
-
Pensacola, Florida, United States, 32504
- Recruiting
- Ascension Sacred Heart
-
Principal Investigator:
- Rohit Amin, MD
-
Tampa, Florida, United States, 33606
- Recruiting
- Tampa General Hospital
-
Principal Investigator:
- Jason Feliberti, MD
-
-
Georgia
-
Decatur, Georgia, United States, 30032
- Recruiting
- Atlanta VA Health Care System
-
Principal Investigator:
- Gautum Kumar, MD
-
-
Illinois
-
Naperville, Illinois, United States, 60540
- Recruiting
- Midwest Cardiovascular Institute
-
Principal Investigator:
- Stanislaw Skaluba, MD
-
-
Louisiana
-
Houma, Louisiana, United States, 70360
- Recruiting
- Cardiovascular Institute of the South
-
Principal Investigator:
- Peter Fail, MD
-
New Orleans, Louisiana, United States, 70112
- Recruiting
- University Medical Center New Orleans
-
Principal Investigator:
- Frank Smart, MD
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Principal Investigator:
- Pinak Shah, MD
-
Boston, Massachusetts, United States, 02118
- Recruiting
- Boston Medical Center
-
Principal Investigator:
- Nir Ayalon, MD
-
Boston, Massachusetts, United States, 02111
- Recruiting
- Tufts Medical Center
-
Principal Investigator:
- Jeong Hwan Kim, MD
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Recruiting
- Minneapolis Heart Institute Foundation
-
Principal Investigator:
- Peter Eckman, MD
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University - St Louis
-
Principal Investigator:
- Ali Javaheri, MD, PhD
-
-
Nevada
-
Las Vegas, Nevada, United States, 89102
- Recruiting
- UMC of Southern Nevada
-
Principal Investigator:
- Ahsan Chowdhury
-
-
New Jersey
-
Browns Mills, New Jersey, United States, 08015
- Recruiting
- Deborah Heart & Lung Center
-
Principal Investigator:
- Geurys Rojas-Marte
-
Englewood, New Jersey, United States, 07631
- Recruiting
- Englewood Medical Center
-
Principal Investigator:
- Ramin Hastings
-
-
New York
-
New York, New York, United States, 11794
- Recruiting
- Stony Brook Medicine
-
Principal Investigator:
- Ahmad Alkhalil, MD
-
Rochester, New York, United States, 14621
- Recruiting
- Rochester General Hospital
-
Principal Investigator:
- Elizabeth Lee, MD
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Recruiting
- Mission Hospital
-
Principal Investigator:
- Vinay Thohan, MD
-
Durham, North Carolina, United States, 27705
- Recruiting
- Duke University Hospital
-
Principal Investigator:
- Robert Mentz, MD, FACC, FAHA, HFSA
-
Raleigh, North Carolina, United States, 27607
- Recruiting
- NC Heart and Vascular Research
-
Principal Investigator:
- Elizabeth Volz, MD
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic
-
Principal Investigator:
- J. Emanuel Finet, MD
-
Toledo, Ohio, United States, 43606
- Recruiting
- ProMedica Toledo Hospital
-
Principal Investigator:
- P. Kasi Ramanathan, MD
-
-
Pennsylvania
-
Harrisburg, Pennsylvania, United States, 17101
- Recruiting
- Pinnacle Health Cardiovascular Institute
-
Principal Investigator:
- Hemal Gada, MD
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Principal Investigator:
- Brian Houston, MD
-
Charleston, South Carolina, United States, 29414
- Recruiting
- Roper St. Francis Healthcare
-
Principal Investigator:
- Matthew O'Steen, MD
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57701
- Recruiting
- Monument Health
-
Principal Investigator:
- Luis Hernandez, MD
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37934
- Recruiting
- Tennova Healthcare - Turkey Creek Medical Center
-
Principal Investigator:
- Malcolm Foster
-
-
Texas
-
Abilene, Texas, United States, 79601
- Recruiting
- Hendrick Health
-
Principal Investigator:
- Mark Lawrence, D.O.
-
Austin, Texas, United States, 78756
- Recruiting
- Austin Heart
-
Principal Investigator:
- Kunjan Bhatt, MD
-
Austin, Texas, United States, 78705
- Recruiting
- Texas Cardiac Arrhythmia Research Foundation
-
Principal Investigator:
- Huseng Vefali, MD
-
Plano, Texas, United States, 75093
- Recruiting
- Baylor Scott & White Research Institute
-
Principal Investigator:
- Molly Szerlip
-
Temple, Texas, United States, 76508
- Recruiting
- Baylor Scott & White - Temple
-
Principal Investigator:
- Ernesto Ruiz Duque, MD
-
Waco, Texas, United States, 76712
- Recruiting
- Waco Cardiology
-
Principal Investigator:
- Donald Cross, MD
-
-
Virginia
-
Roanoke, Virginia, United States, 24014
- Recruiting
- Carilion Clinic
-
Principal Investigator:
- Daniel Pauly, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- LVEF ≤ 40%
- NYHA class II, III or ambulatory IV HF
- Receiving optimal, maximally tolerated, stable GDMT
Exclusion Criteria:
- Advanced heart failure
- Life-expectancy < 12 months
- Evidence of right heart dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
Subjects randomized to the treatment arm will undergo cardiac imaging, femoral vein access and receive the Alleviant ALV1 System device procedure.
|
Creation of interatrial shunt
|
|
Sham Comparator: Control
Subjects randomized to the control arm will undergo cardiac imaging and sheath placement in femoral vein.
|
Cardiac imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite Primary Endpoint
Time Frame: 12-Month
|
The primary endpoint is a composite of all-cause mortality or cardiac transplantation or permanent left ventricular assist device (LVAD) and heart failure events.
|
12-Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gregg Stone, Icahn School of Medicine at Mount Sinai
- Principal Investigator: James Udelson, Tufts Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
February 3, 2025
First Submitted That Met QC Criteria
February 3, 2025
First Posted (Actual)
February 6, 2025
Study Record Updates
Last Update Posted (Actual)
August 14, 2026
Last Update Submitted That Met QC Criteria
August 12, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIP-0006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.